xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1304.xml | 1304 | 2025-11-06-08:00 | 15784906 | 2,005 | Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. | The Journal of general virology | Aleksandr S Lipatov; Samita Andreansky; Richard J Webby; Diane J Hulse; Jerold E Rehg; Scott Krauss; Daniel R Perez; Peter C Doherty; Robert G Webster; Mark Y Sangster | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 211044 | null | null | Exact Epitope | Not determined | TCell | 19647 | 47 | Table 1 | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Internal Identifier-no external match available | null | 9 |
1304.xml | 1304 | 2025-11-06-08:00 | 15784906 | 2,005 | Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. | The Journal of general virology | Aleksandr S Lipatov; Samita Andreansky; Richard J Webby; Diane J Hulse; Jerold E Rehg; Scott Krauss; Daniel R Perez; Peter C Doherty; Robert G Webster; Mark Y Sangster | 61151 | PA 224-233 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SSLENFRAYV | 10 | null | 224 | 233 | 211044 | null | null | Exact Epitope | Not determined | TCell | 19648 | 47 | Table 1 | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Internal Identifier-no external match available | null | 1 |
1304.xml | 1304 | 2025-11-06-08:00 | 15784906 | 2,005 | Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. | The Journal of general virology | Aleksandr S Lipatov; Samita Andreansky; Richard J Webby; Diane J Hulse; Jerold E Rehg; Scott Krauss; Daniel R Perez; Peter C Doherty; Robert G Webster; Mark Y Sangster | 61497 | PB1 703-711 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SSYRRPVGI | 9 | null | 703 | 711 | 211044 | P03431.2 | null | Exact Epitope | Not determined | TCell | 19649 | 47 | Table 1 | Positive | true | null | 10000067 | null | null | null | 122 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110495 | MAb 6B2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E311 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 20038 | 34 | Figure 1 | Positive | true | null | 10000000 | null | null | ONTIE:0003423 | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 1 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110495 | MAb 6B2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E311 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 20039 | 316 | Table II | Positive | true | null | 10000000 | null | null | ONTIE:0003423 | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 1 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110495 | MAb 6B2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E311 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 1641452 | 308 | Table I | Positive | true | null | 9606 | null | null | DOID:12205 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110501 | MAb 10F2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | T69 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 20044 | 34 | Figure 1 | Positive | true | null | 10000000 | null | null | ONTIE:0003423 | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 3 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110501 | MAb 10F2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | T69 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 20045 | 316 | Table II | Positive | true | null | 10000000 | null | null | ONTIE:0003423 | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 3 |
1305.xml | 1305 | 2023-08-18-07:00 | 11536239 | 2,001 | Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. | Journal of medical virology | S M Lok; M L Ng; J Aaskov | 110501 | MAb 10F2- Envelope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | T69 | null | null | 11065 | ABX25775.1 | null | Partial Epitope | Exact match to reference information | BCell | 1641455 | 308 | Table I | Positive | true | null | 9606 | null | null | DOID:12205 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1313.xml | 1313 | 2025-11-06-08:00 | 12421934 | 2,002 | Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes. | Journal of immunology (Baltimore, Md. : 1950) | Eve Cheuk; Celine D'Souza; Ningjie Hu; Youan Liu; Haili Lang; John W Chamberlain | 60867 | NP383-391 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 132504 | Q91UL1.1 | null | Exact Epitope | Not determined | TCell | 20336 | 67 | Figure 6B (ii) | Positive | true | null | 10000229 | null | null | null | 190 | 190 | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Not determined | null | 7 |
1313.xml | 1313 | 2025-11-06-08:00 | 12421934 | 2,002 | Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes. | Journal of immunology (Baltimore, Md. : 1950) | Eve Cheuk; Celine D'Souza; Ningjie Hu; Youan Liu; Haili Lang; John W Chamberlain | 38469 | NP418-426 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPFDRTTVM | 9 | null | 418 | 426 | 211044 | null | null | Exact Epitope | Not determined | TCell | 20524 | 67 | Figure 7B (i) | Positive | true | null | 10001782 | null | null | null | 251 | 251 | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Not determined | null | 1 |
1313.xml | 1313 | 2025-11-06-08:00 | 12421934 | 2,002 | Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes. | Journal of immunology (Baltimore, Md. : 1950) | Eve Cheuk; Celine D'Souza; Ningjie Hu; Youan Liu; Haili Lang; John W Chamberlain | 4602 | NP366-372 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 132504 | Q91UL1.1 | null | Exact Epitope | Not determined | TCell | 20686 | 67 | Figure 6A (i) | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Not determined | null | 9 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 12992 | SEA 154-161 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELDLQARR | 8 | null | 178 | 185 | 1280 | P0A0L2.1 | null | Exact Epitope | Not determined | BCell | 20420 | 633 | Figure 4 | Positive | true | null | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 1 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 12992 | SEA 154-161 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELDLQARR | 8 | null | 178 | 185 | 1280 | P0A0L2.1 | null | Exact Epitope | Not determined | BCell | 20337 | 316 | Figure 2A | Positive | true | null | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 1 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 12992 | SEA 154-161 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELDLQARR | 8 | null | 178 | 185 | 1280 | P0A0L2.1 | null | Exact Epitope | Not determined | BCell | 20316 | 253 | Figure 1A Figure 5 | Positive | true | 780.0 | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 1 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 76606 | TSST-1 51-56 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YYSPAF | 6 | null | 91 | 96 | 1280 | P06886.1 | null | Exact Epitope | Not determined | BCell | 20441 | 316 | Figure 2A | Positive | true | null | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 9 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 76606 | TSST-1 51-56 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YYSPAF | 6 | null | 91 | 96 | 1280 | P06886.1 | null | Exact Epitope | Not determined | BCell | 20440 | 253 | Figure 1A Figure 6 | Positive | true | 0.9 | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 9 |
1314.xml | 1314 | 2026-02-03-08:00 | 11372026 | 2,001 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | The Journal of infectious diseases | W W Kum; A W Chow | 10588 | SEB 83-92 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DVFGANYYYQ | 10 | null | 110 | 119 | 1280 | P01552.1 | null | Exact Epitope | Not determined | BCell | 20477 | 34 | Figure 6 | Positive | true | null | 10000000 | F | 8 weeks | ONTIE:0003423 | null | null | null | null | null | Not determined | Not determined | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1509 | CII 261-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AGFKGEQGPKGEP | 13 | null | 461 | 473 | 9606 | P02458.3 | null | Exact Epitope | Not determined | TCell | 1006457 | 62 | Table 1 | Positive | true | null | 10000610 | null | null | null | 341 | null | T cell | null | Cell Line / Clone (Hybridoma) | Exact match to reference information | null | null | 2 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1509 | CII 261-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AGFKGEQGPKGEP | 13 | null | 461 | 473 | 9606 | P02458.3 | null | Exact Epitope | Not determined | TCell | 20478 | 62 | Table 1 | Positive | true | null | 10000601 | null | null | null | 327 | null | T cell | null | Cell Line / Clone (Hybridoma) | Exact match to reference information | null | null | 2 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1509 | CII 261-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AGFKGEQGPKGEP | 13 | null | 461 | 473 | 9606 | P02458.3 | null | Exact Epitope | Not determined | MhcBinding | 1006461 | 295 | Table 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1509 | CII 261-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AGFKGEQGPKGEP | 13 | null | 461 | 473 | 9606 | P02458.3 | null | Exact Epitope | Not determined | MhcBinding | 1006460 | 295 | Table 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 48237 | HA 306-318 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | AAA43143.1 | null | Exact Epitope | Not determined | MhcBinding | 1006523 | 295 | Table 1, Figures 1 and 2 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 48237 | HA 306-318 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | AAA43143.1 | null | Exact Epitope | Not determined | MhcBinding | 1006524 | 295 | Table 1, Figures 1 and 2 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 67 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006525 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 67 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006528 | 273 | Table 1 | Positive | true | 27000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1030 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006841 | 273 | Table 1 | Positive | true | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1030 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006840 | 273 | Table 1 | Positive | true | 11000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2182 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006842 | 273 | Table 1 | Positive | true | 9000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2182 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006843 | 273 | Table 1 | Positive | true | 66000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2227 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006844 | 273 | Table 1 | Positive | true | 9000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2227 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006845 | 273 | Table 1 | Positive | true | 66000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006847 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006846 | 273 | Table 1 | Positive | true | 40000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 30314 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KEAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006848 | 273 | Table 1 | Positive | true | 6000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 30314 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KEAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006849 | 273 | Table 1 | Positive | true | 85000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 896 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006850 | 273 | Table 1 | Positive | true | 3000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 896 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006851 | 273 | Table 1 | Positive | true | 80000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 126 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006852 | 273 | Table 1 | Positive | true | 3000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 126 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAEYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006853 | 273 | Table 1 | Positive | true | 42000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12634 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006855 | 273 | Table 1 | Positive | true | 130000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12634 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006854 | 273 | Table 1 | Positive | true | 7000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 261 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYEAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006856 | 273 | Table 1 | Positive | true | 5000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 261 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYEAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006857 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 259 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYAEAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006859 | 273 | Table 1 | Positive | true | 38000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 259 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYAEAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006858 | 273 | Table 1 | Positive | true | 2000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 10999 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006860 | 273 | Table 1 | Positive | true | 9000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 10999 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAAYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006861 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12786 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006862 | 273 | Table 1 | Positive | true | 5000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12786 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006863 | 273 | Table 1 | Positive | true | 56000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 11106 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006864 | 273 | Table 1 | Positive | true | 5000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 11106 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAKYAAAAAAKAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006865 | 273 | Table 1 | Positive | true | 33000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1029 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006869 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1029 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006870 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2181 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKEYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006872 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2181 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKEYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006871 | 273 | Table 1 | Positive | true | 130000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2229 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006877 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2229 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006876 | 273 | Table 1 | Positive | true | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2228 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYAEAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006879 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2228 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKKYAEAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006878 | 273 | Table 1 | Positive | true | 78000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEAYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006881 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEAYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006880 | 273 | Table 1 | Positive | true | 44000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 30313 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KEAYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006883 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 30313 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KEAYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006884 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 897 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEEYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006885 | 273 | Table 1 | Negative | false | 150000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 897 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEEYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006886 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 128 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAEYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006888 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 128 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAEYKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006887 | 273 | Table 1 | Positive | true | 23000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 258 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYAEAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006893 | 273 | Table 1 | Positive | true | 60000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 258 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AAKYAEAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006894 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12785 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006896 | 273 | Table 1 | Positive | true | 28000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12785 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006897 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 11105 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006899 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 11105 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EAKYAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006898 | 273 | Table 1 | Positive | true | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1237 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEYAKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006901 | 273 | Table 1 | Positive | true | 70000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1237 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEYAKAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006902 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1009 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKAYAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006903 | 273 | Table 1 | Positive | true | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 1009 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AEKAYAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006904 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12908 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKYAAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006905 | 273 | Table 1 | Positive | true | 140000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 12908 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | EKYAAAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006906 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 5848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYKAEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006907 | 273 | Table 1 | Positive | true | 78000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 5848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYKAEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006908 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2325 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKYAEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006910 | 273 | Table 1 | Negative | false | 1000000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 2325 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AKYAEAAAAAAAAAA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006909 | 273 | Table 1 | Positive | true | 110000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 3631 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APKYVKQNTLKLATA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006911 | 273 | Table 1 | Positive | true | 28000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1316.xml | 1316 | 2025-11-06-08:00 | 10880734 | 2,000 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. | Human immunology | M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger | 3631 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APKYVKQNTLKLATA | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1006912 | 273 | Table 1 | Positive | true | 13000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20687 | 69 | Figure 3 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20690 | 182 | Table 3 | Negative | false | null | 10000219 | F | 6-12 weeks | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20683 | 69 | Figure 2A | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | lymphocyte | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20685 | 69 | Figure 2A | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | lymphocyte | lymphoid | Direct Ex Vivo | Not determined | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20673 | 73 | Table 1 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | lymphocyte | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20675 | 73 | Figure 1 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20688 | 69 | Figure 3 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | splenocyte | spleen | Direct Ex Vivo | Not determined | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 42797 | ESAT-6 1-20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MTEQQWNFAGIEAAASAIQG | 20 | null | 1 | 20 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20674 | 73 | Table 1 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 181 | null | lymphocyte | lymphoid | Direct Ex Vivo | Not determined | Exact match to reference information | null | 2 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20692 | 73 | Table 1 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | lymphocyte | lymphoid | Direct Ex Vivo | Not determined | Exact match to reference information | null | 8 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20695 | 69 | Figure 2B | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | lymphocyte | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20697 | 69 | Figure 3 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20691 | 73 | Table 1 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | lymphocyte | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20696 | 69 | Figure 2B | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | lymphocyte | lymphoid | Direct Ex Vivo | Not determined | Exact match to reference information | null | 8 |
1317.xml | 1317 | 2026-02-03-08:00 | 10898510 | 2,000 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | European journal of immunology | A W Olsen; P R Hansen; A Holm; P Andersen | 75495 | ESAT-6 51-70 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YQGVQQKWDATATELNNALQ | 20 | null | 51 | 70 | 83332 | P0A564.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 20698 | 69 | Figure 3 | Positive | true | null | 10000219 | F | 6-12 weeks | null | 110 | null | splenocyte | spleen | Direct Ex Vivo | Not determined | Exact match to reference information | null | 8 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.